liver cancer neoantigens-sensitized autoimmune cells IPM001

A preparation of autoimmune cells that have been sensitized to liver cancer neoantigens, with potential immunostimulating and antineoplastic activities, Upon administration of the liver cancer neoantigens-sensitized autoimmune cells IPM001, these cells may eradicate the liver cancer cells.